During the past decade, CCBR - Buenos Aires - AR; AxisMed SRL conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CCBR - Buenos Aires - AR; AxisMed SRL" are "Cardiovascular Disease" (2 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "CCBR - Buenos Aires - AR; AxisMed SRL" in a lesser frequency.

Most popular intervention types in "CCBR - Buenos Aires - AR; AxisMed SRL" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GDC-0853" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Adalimumab" (1 trials) and "Folic Acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "CCBR - Buenos Aires - AR; AxisMed SRL" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CCBR - Buenos Aires - AR; AxisMed SRL". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CCBR - Buenos Aires - AR; AxisMed SRL, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CCBR - Buenos Aires - AR; AxisMed SRL, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".